Analyst: Great financial statement from Novo
Novo Nordisk has once again surpassed market expectations with a great financial statement, says an analyst.
by Kresten Morten Munksgaard
“The financial statement surpasses expectations for turnover and operating profit for Q4,” analyst Søren Løntoft told Medwatch shortly after the publication of the yearly financial statement from Denmark’s largest pharmaceutical company Novo Nordisk last week - a financial statement that exceeded expectations once again.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
- Adgang til alle låste artikler
- Modtag vores daglige nyhedsbreve
- Fuld adgang til vores app
.jpg&w=384&q=75){kind=logo}
